Global Noninvasive Prenatal Gene Testing Technology Market 2023 by Company, Regions, Type and Application, Forecast to 2029

  • receipt Report ID : 150580
  • calendar_today Published On: Mar, 2023
  • file_copy Pages: 165
  • list Medical Devices
Buy @ $3500

According to our latest study, the global Noninvasive Prenatal Gene Testing Technology market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

This report is a detailed and comprehensive analysis for global Noninvasive Prenatal Gene Testing Technology market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:

Global Noninvasive Prenatal Gene Testing Technology market size and forecasts, in consumption value ($ Million), 2018-2029

Global Noninvasive Prenatal Gene Testing Technology market size and forecasts by region and country, in consumption value ($ Million), 2018-2029

Global Noninvasive Prenatal Gene Testing Technology market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029

Global Noninvasive Prenatal Gene Testing Technology market shares of main players, in revenue ($ Million), 2018-2023

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Noninvasive Prenatal Gene Testing Technology

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Noninvasive Prenatal Gene Testing Technology market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Illumina, Natera, LifeLabs, NiftyTest and Labcorp, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market segmentation

Noninvasive Prenatal Gene Testing Technology market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type

NIPT

NIPT Plus

Market segment by Application

Chromosomal Abnormalities

Assisted Reproduction

Others

Market segment by players, this report covers

Illumina

Natera

LifeLabs

NiftyTest

Labcorp

Xcelom

Veritas

Sema4

CeGaT

BGI

Berry Genomics

Daan Gene

CapitalBio

Annoroad

Adicon

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)

South America (Brazil, Argentina and Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:

Chapter 1, to describe Noninvasive Prenatal Gene Testing Technology product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top players of Noninvasive Prenatal Gene Testing Technology, with revenue, gross margin and global market share of Noninvasive Prenatal Gene Testing Technology from 2018 to 2023.

Chapter 3, the Noninvasive Prenatal Gene Testing Technology competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Noninvasive Prenatal Gene Testing Technology market forecast, by regions, type and application, with consumption value, from 2024 to 2029.

Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War

Chapter 12, the key raw materials and key suppliers, and industry chain of Noninvasive Prenatal Gene Testing Technology.

Chapter 13, to describe Noninvasive Prenatal Gene Testing Technology research findings and conclusion.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of Noninvasive Prenatal Gene Testing Technology

1.2 Market Estimation Caveats and Base Year

1.3 Classification of Noninvasive Prenatal Gene Testing Technology by Type

1.3.1 Overview: Global Noninvasive Prenatal Gene Testing Technology Market Size by Type: 2018 Versus 2022 Versus 2029

1.3.2 Global Noninvasive Prenatal Gene Testing Technology Consumption Value Market Share by Type in 2022

1.3.3 NIPT

1.3.4 NIPT Plus

1.4 Global Noninvasive Prenatal Gene Testing Technology Market by Application

1.4.1 Overview: Global Noninvasive Prenatal Gene Testing Technology Market Size by Application: 2018 Versus 2022 Versus 2029

1.4.2 Chromosomal Abnormalities

1.4.3 Assisted Reproduction

1.4.4 Others

1.5 Global Noninvasive Prenatal Gene Testing Technology Market Size & Forecast

1.6 Global Noninvasive Prenatal Gene Testing Technology Market Size and Forecast by Region

1.6.1 Global Noninvasive Prenatal Gene Testing Technology Market Size by Region: 2018 VS 2022 VS 2029

1.6.2 Global Noninvasive Prenatal Gene Testing Technology Market Size by Region, (2018-2029)

1.6.3 North America Noninvasive Prenatal Gene Testing Technology Market Size and Prospect (2018-2029)

1.6.4 Europe Noninvasive Prenatal Gene Testing Technology Market Size and Prospect (2018-2029)

1.6.5 Asia-Pacific Noninvasive Prenatal Gene Testing Technology Market Size and Prospect (2018-2029)

1.6.6 South America Noninvasive Prenatal Gene Testing Technology Market Size and Prospect (2018-2029)

1.6.7 Middle East and Africa Noninvasive Prenatal Gene Testing Technology Market Size and Prospect (2018-2029)

2 Company Profiles

2.1 Illumina

2.1.1 Illumina Details

2.1.2 Illumina Major Business

2.1.3 Illumina Noninvasive Prenatal Gene Testing Technology Product and Solutions

2.1.4 Illumina Noninvasive Prenatal Gene Testing Technology Revenue, Gross Margin and Market Share (2018-2023)

2.1.5 Illumina Recent Developments and Future Plans

2.2 Natera

2.2.1 Natera Details

2.2.2 Natera Major Business

2.2.3 Natera Noninvasive Prenatal Gene Testing Technology Product and Solutions

2.2.4 Natera Noninvasive Prenatal Gene Testing Technology Revenue, Gross Margin and Market Share (2018-2023)

2.2.5 Natera Recent Developments and Future Plans

2.3 LifeLabs

2.3.1 LifeLabs Details

2.3.2 LifeLabs Major Business

2.3.3 LifeLabs Noninvasive Prenatal Gene Testing Technology Product and Solutions

2.3.4 LifeLabs Noninvasive Prenatal Gene Testing Technology Revenue, Gross Margin and Market Share (2018-2023)

2.3.5 LifeLabs Recent Developments and Future Plans

2.4 NiftyTest

2.4.1 NiftyTest Details

2.4.2 NiftyTest Major Business

2.4.3 NiftyTest Noninvasive Prenatal Gene Testing Technology Product and Solutions

2.4.4 NiftyTest Noninvasive Prenatal Gene Testing Technology Revenue, Gross Margin and Market Share (2018-2023)

2.4.5 NiftyTest Recent Developments and Future Plans

2.5 Labcorp

2.5.1 Labcorp Details

2.5.2 Labcorp Major Business

2.5.3 Labcorp Noninvasive Prenatal Gene Testing Technology Product and Solutions

2.5.4 Labcorp Noninvasive Prenatal Gene Testing Technology Revenue, Gross Margin and Market Share (2018-2023)

2.5.5 Labcorp Recent Developments and Future Plans

2.6 Xcelom

2.6.1 Xcelom Details

2.6.2 Xcelom Major Business

2.6.3 Xcelom Noninvasive Prenatal Gene Testing Technology Product and Solutions

2.6.4 Xcelom Noninvasive Prenatal Gene Testing Technology Revenue, Gross Margin and Market Share (2018-2023)

2.6.5 Xcelom Recent Developments and Future Plans

2.7 Veritas

2.7.1 Veritas Details

2.7.2 Veritas Major Business

2.7.3 Veritas Noninvasive Prenatal Gene Testing Technology Product and Solutions

2.7.4 Veritas Noninvasive Prenatal Gene Testing Technology Revenue, Gross Margin and Market Share (2018-2023)

2.7.5 Veritas Recent Developments and Future Plans

2.8 Sema4

2.8.1 Sema4 Details

2.8.2 Sema4 Major Business

2.8.3 Sema4 Noninvasive Prenatal Gene Testing Technology Product and Solutions

2.8.4 Sema4 Noninvasive Prenatal Gene Testing Technology Revenue, Gross Margin and Market Share (2018-2023)

2.8.5 Sema4 Recent Developments and Future Plans

2.9 CeGaT

2.9.1 CeGaT Details

2.9.2 CeGaT Major Business

2.9.3 CeGaT Noninvasive Prenatal Gene Testing Technology Product and Solutions

2.9.4 CeGaT Noninvasive Prenatal Gene Testing Technology Revenue, Gross Margin and Market Share (2018-2023)

2.9.5 CeGaT Recent Developments and Future Plans

2.10 BGI

2.10.1 BGI Details

2.10.2 BGI Major Business

2.10.3 BGI Noninvasive Prenatal Gene Testing Technology Product and Solutions

2.10.4 BGI Noninvasive Prenatal Gene Testing Technology Revenue, Gross Margin and Market Share (2018-2023)

2.10.5 BGI Recent Developments and Future Plans

2.11 Berry Genomics

2.11.1 Berry Genomics Details

2.11.2 Berry Genomics Major Business

2.11.3 Berry Genomics Noninvasive Prenatal Gene Testing Technology Product and Solutions

2.11.4 Berry Genomics Noninvasive Prenatal Gene Testing Technology Revenue, Gross Margin and Market Share (2018-2023)

2.11.5 Berry Genomics Recent Developments and Future Plans

2.12 Daan Gene

2.12.1 Daan Gene Details

2.12.2 Daan Gene Major Business

2.12.3 Daan Gene Noninvasive Prenatal Gene Testing Technology Product and Solutions

2.12.4 Daan Gene Noninvasive Prenatal Gene Testing Technology Revenue, Gross Margin and Market Share (2018-2023)

2.12.5 Daan Gene Recent Developments and Future Plans

2.13 CapitalBio

2.13.1 CapitalBio Details

2.13.2 CapitalBio Major Business

2.13.3 CapitalBio Noninvasive Prenatal Gene Testing Technology Product and Solutions

2.13.4 CapitalBio Noninvasive Prenatal Gene Testing Technology Revenue, Gross Margin and Market Share (2018-2023)

2.13.5 CapitalBio Recent Developments and Future Plans

2.14 Annoroad

2.14.1 Annoroad Details

2.14.2 Annoroad Major Business

2.14.3 Annoroad Noninvasive Prenatal Gene Testing Technology Product and Solutions

2.14.4 Annoroad Noninvasive Prenatal Gene Testing Technology Revenue, Gross Margin and Market Share (2018-2023)

2.14.5 Annoroad Recent Developments and Future Plans

2.15 Adicon

2.15.1 Adicon Details

2.15.2 Adicon Major Business

2.15.3 Adicon Noninvasive Prenatal Gene Testing Technology Product and Solutions

2.15.4 Adicon Noninvasive Prenatal Gene Testing Technology Revenue, Gross Margin and Market Share (2018-2023)

2.15.5 Adicon Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Noninvasive Prenatal Gene Testing Technology Revenue and Share by Players (2018-2023)

3.2 Market Share Analysis (2022)

3.2.1 Market Share of Noninvasive Prenatal Gene Testing Technology by Company Revenue

3.2.2 Top 3 Noninvasive Prenatal Gene Testing Technology Players Market Share in 2022

3.2.3 Top 6 Noninvasive Prenatal Gene Testing Technology Players Market Share in 2022

3.3 Noninvasive Prenatal Gene Testing Technology Market: Overall Company Footprint Analysis

3.3.1 Noninvasive Prenatal Gene Testing Technology Market: Region Footprint

3.3.2 Noninvasive Prenatal Gene Testing Technology Market: Company Product Type Footprint

3.3.3 Noninvasive Prenatal Gene Testing Technology Market: Company Product Application Footprint

3.4 New Market Entrants and Barriers to Market Entry

3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

4.1 Global Noninvasive Prenatal Gene Testing Technology Consumption Value and Market Share by Type (2018-2023)

4.2 Global Noninvasive Prenatal Gene Testing Technology Market Forecast by Type (2024-2029)

5 Market Size Segment by Application

5.1 Global Noninvasive Prenatal Gene Testing Technology Consumption Value Market Share by Application (2018-2023)

5.2 Global Noninvasive Prenatal Gene Testing Technology Market Forecast by Application (2024-2029)

6 North America

6.1 North America Noninvasive Prenatal Gene Testing Technology Consumption Value by Type (2018-2029)

6.2 North America Noninvasive Prenatal Gene Testing Technology Consumption Value by Application (2018-2029)

6.3 North America Noninvasive Prenatal Gene Testing Technology Market Size by Country

6.3.1 North America Noninvasive Prenatal Gene Testing Technology Consumption Value by Country (2018-2029)

6.3.2 United States Noninvasive Prenatal Gene Testing Technology Market Size and Forecast (2018-2029)

6.3.3 Canada Noninvasive Prenatal Gene Testing Technology Market Size and Forecast (2018-2029)

6.3.4 Mexico Noninvasive Prenatal Gene Testing Technology Market Size and Forecast (2018-2029)

7 Europe

7.1 Europe Noninvasive Prenatal Gene Testing Technology Consumption Value by Type (2018-2029)

7.2 Europe Noninvasive Prenatal Gene Testing Technology Consumption Value by Application (2018-2029)

7.3 Europe Noninvasive Prenatal Gene Testing Technology Market Size by Country

7.3.1 Europe Noninvasive Prenatal Gene Testing Technology Consumption Value by Country (2018-2029)

7.3.2 Germany Noninvasive Prenatal Gene Testing Technology Market Size and Forecast (2018-2029)

7.3.3 France Noninvasive Prenatal Gene Testing Technology Market Size and Forecast (2018-2029)

7.3.4 United Kingdom Noninvasive Prenatal Gene Testing Technology Market Size and Forecast (2018-2029)

7.3.5 Russia Noninvasive Prenatal Gene Testing Technology Market Size and Forecast (2018-2029)

7.3.6 Italy Noninvasive Prenatal Gene Testing Technology Market Size and Forecast (2018-2029)

8 Asia-Pacific

8.1 Asia-Pacific Noninvasive Prenatal Gene Testing Technology Consumption Value by Type (2018-2029)

8.2 Asia-Pacific Noninvasive Prenatal Gene Testing Technology Consumption Value by Application (2018-2029)

8.3 Asia-Pacific Noninvasive Prenatal Gene Testing Technology Market Size by Region

8.3.1 Asia-Pacific Noninvasive Prenatal Gene Testing Technology Consumption Value by Region (2018-2029)

8.3.2 China Noninvasive Prenatal Gene Testing Technology Market Size and Forecast (2018-2029)

8.3.3 Japan Noninvasive Prenatal Gene Testing Technology Market Size and Forecast (2018-2029)

8.3.4 South Korea Noninvasive Prenatal Gene Testing Technology Market Size and Forecast (2018-2029)

8.3.5 India Noninvasive Prenatal Gene Testing Technology Market Size and Forecast (2018-2029)

8.3.6 Southeast Asia Noninvasive Prenatal Gene Testing Technology Market Size and Forecast (2018-2029)

8.3.7 Australia Noninvasive Prenatal Gene Testing Technology Market Size and Forecast (2018-2029)

9 South America

9.1 South America Noninvasive Prenatal Gene Testing Technology Consumption Value by Type (2018-2029)

9.2 South America Noninvasive Prenatal Gene Testing Technology Consumption Value by Application (2018-2029)

9.3 South America Noninvasive Prenatal Gene Testing Technology Market Size by Country

9.3.1 South America Noninvasive Prenatal Gene Testing Technology Consumption Value by Country (2018-2029)

9.3.2 Brazil Noninvasive Prenatal Gene Testing Technology Market Size and Forecast (2018-2029)

9.3.3 Argentina Noninvasive Prenatal Gene Testing Technology Market Size and Forecast (2018-2029)

10 Middle East & Africa

10.1 Middle East & Africa Noninvasive Prenatal Gene Testing Technology Consumption Value by Type (2018-2029)

10.2 Middle East & Africa Noninvasive Prenatal Gene Testing Technology Consumption Value by Application (2018-2029)

10.3 Middle East & Africa Noninvasive Prenatal Gene Testing Technology Market Size by Country

10.3.1 Middle East & Africa Noninvasive Prenatal Gene Testing Technology Consumption Value by Country (2018-2029)

10.3.2 Turkey Noninvasive Prenatal Gene Testing Technology Market Size and Forecast (2018-2029)

10.3.3 Saudi Arabia Noninvasive Prenatal Gene Testing Technology Market Size and Forecast (2018-2029)

10.3.4 UAE Noninvasive Prenatal Gene Testing Technology Market Size and Forecast (2018-2029)

11 Market Dynamics

11.1 Noninvasive Prenatal Gene Testing Technology Market Drivers

11.2 Noninvasive Prenatal Gene Testing Technology Market Restraints

11.3 Noninvasive Prenatal Gene Testing Technology Trends Analysis

11.4 Porters Five Forces Analysis

11.4.1 Threat of New Entrants

11.4.2 Bargaining Power of Suppliers

11.4.3 Bargaining Power of Buyers

11.4.4 Threat of Substitutes

11.4.5 Competitive Rivalry

11.5 Influence of COVID-19 and Russia-Ukraine War

11.5.1 Influence of COVID-19

11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis

12.1 Noninvasive Prenatal Gene Testing Technology Industry Chain

12.2 Noninvasive Prenatal Gene Testing Technology Upstream Analysis

12.3 Noninvasive Prenatal Gene Testing Technology Midstream Analysis

12.4 Noninvasive Prenatal Gene Testing Technology Downstream Analysis

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Research Process and Data Source

14.3 Disclaimer

List of Tables

Table 1. Global Noninvasive Prenatal Gene Testing Technology Consumption Value by Type, (USD Million), 2018 & 2022 & 2029

Table 2. Global Noninvasive Prenatal Gene Testing Technology Consumption Value by Application, (USD Million), 2018 & 2022 & 2029

Table 3. Global Noninvasive Prenatal Gene Testing Technology Consumption Value by Region (2018-2023) & (USD Million)

Table 4. Global Noninvasive Prenatal Gene Testing Technology Consumption Value by Region (2024-2029) & (USD Million)

Table 5. Illumina Company Information, Head Office, and Major Competitors

Table 6. Illumina Major Business

Table 7. Illumina Noninvasive Prenatal Gene Testing Technology Product and Solutions

Table 8. Illumina Noninvasive Prenatal Gene Testing Technology Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 9. Illumina Recent Developments and Future Plans

Table 10. Natera Company Information, Head Office, and Major Competitors

Table 11. Natera Major Business

Table 12. Natera Noninvasive Prenatal Gene Testing Technology Product and Solutions

Table 13. Natera Noninvasive Prenatal Gene Testing Technology Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 14. Natera Recent Developments and Future Plans

Table 15. LifeLabs Company Information, Head Office, and Major Competitors

Table 16. LifeLabs Major Business

Table 17. LifeLabs Noninvasive Prenatal Gene Testing Technology Product and Solutions

Table 18. LifeLabs Noninvasive Prenatal Gene Testing Technology Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 19. LifeLabs Recent Developments and Future Plans

Table 20. NiftyTest Company Information, Head Office, and Major Competitors

Table 21. NiftyTest Major Business

Table 22. NiftyTest Noninvasive Prenatal Gene Testing Technology Product and Solutions

Table 23. NiftyTest Noninvasive Prenatal Gene Testing Technology Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 24. NiftyTest Recent Developments and Future Plans

Table 25. Labcorp Company Information, Head Office, and Major Competitors

Table 26. Labcorp Major Business

Table 27. Labcorp Noninvasive Prenatal Gene Testing Technology Product and Solutions

Table 28. Labcorp Noninvasive Prenatal Gene Testing Technology Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 29. Labcorp Recent Developments and Future Plans

Table 30. Xcelom Company Information, Head Office, and Major Competitors

Table 31. Xcelom Major Business

Table 32. Xcelom Noninvasive Prenatal Gene Testing Technology Product and Solutions

Table 33. Xcelom Noninvasive Prenatal Gene Testing Technology Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 34. Xcelom Recent Developments and Future Plans

Table 35. Veritas Company Information, Head Office, and Major Competitors

Table 36. Veritas Major Business

Table 37. Veritas Noninvasive Prenatal Gene Testing Technology Product and Solutions

Table 38. Veritas Noninvasive Prenatal Gene Testing Technology Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 39. Veritas Recent Developments and Future Plans

Table 40. Sema4 Company Information, Head Office, and Major Competitors

Table 41. Sema4 Major Business

Table 42. Sema4 Noninvasive Prenatal Gene Testing Technology Product and Solutions

Table 43. Sema4 Noninvasive Prenatal Gene Testing Technology Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 44. Sema4 Recent Developments and Future Plans

Table 45. CeGaT Company Information, Head Office, and Major Competitors

Table 46. CeGaT Major Business

Table 47. CeGaT Noninvasive Prenatal Gene Testing Technology Product and Solutions

Table 48. CeGaT Noninvasive Prenatal Gene Testing Technology Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 49. CeGaT Recent Developments and Future Plans

Table 50. BGI Company Information, Head Office, and Major Competitors

Table 51. BGI Major Business

Table 52. BGI Noninvasive Prenatal Gene Testing Technology Product and Solutions

Table 53. BGI Noninvasive Prenatal Gene Testing Technology Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 54. BGI Recent Developments and Future Plans

Table 55. Berry Genomics Company Information, Head Office, and Major Competitors

Table 56. Berry Genomics Major Business

Table 57. Berry Genomics Noninvasive Prenatal Gene Testing Technology Product and Solutions

Table 58. Berry Genomics Noninvasive Prenatal Gene Testing Technology Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 59. Berry Genomics Recent Developments and Future Plans

Table 60. Daan Gene Company Information, Head Office, and Major Competitors

Table 61. Daan Gene Major Business

Table 62. Daan Gene Noninvasive Prenatal Gene Testing Technology Product and Solutions

Table 63. Daan Gene Noninvasive Prenatal Gene Testing Technology Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 64. Daan Gene Recent Developments and Future Plans

Table 65. CapitalBio Company Information, Head Office, and Major Competitors

Table 66. CapitalBio Major Business

Table 67. CapitalBio Noninvasive Prenatal Gene Testing Technology Product and Solutions

Table 68. CapitalBio Noninvasive Prenatal Gene Testing Technology Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 69. CapitalBio Recent Developments and Future Plans

Table 70. Annoroad Company Information, Head Office, and Major Competitors

Table 71. Annoroad Major Business

Table 72. Annoroad Noninvasive Prenatal Gene Testing Technology Product and Solutions

Table 73. Annoroad Noninvasive Prenatal Gene Testing Technology Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 74. Annoroad Recent Developments and Future Plans

Table 75. Adicon Company Information, Head Office, and Major Competitors

Table 76. Adicon Major Business

Table 77. Adicon Noninvasive Prenatal Gene Testing Technology Product and Solutions

Table 78. Adicon Noninvasive Prenatal Gene Testing Technology Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 79. Adicon Recent Developments and Future Plans

Table 80. Global Noninvasive Prenatal Gene Testing Technology Revenue (USD Million) by Players (2018-2023)

Table 81. Global Noninvasive Prenatal Gene Testing Technology Revenue Share by Players (2018-2023)

Table 82. Breakdown of Noninvasive Prenatal Gene Testing Technology by Company Type (Tier 1, Tier 2, and Tier 3)

Table 83. Market Position of Players in Noninvasive Prenatal Gene Testing Technology, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022

Table 84. Head Office of Key Noninvasive Prenatal Gene Testing Technology Players

Table 85. Noninvasive Prenatal Gene Testing Technology Market: Company Product Type Footprint

Table 86. Noninvasive Prenatal Gene Testing Technology Market: Company Product Application Footprint

Table 87. Noninvasive Prenatal Gene Testing Technology New Market Entrants and Barriers to Market Entry

Table 88. Noninvasive Prenatal Gene Testing Technology Mergers, Acquisition, Agreements, and Collaborations

Table 89. Global Noninvasive Prenatal Gene Testing Technology Consumption Value (USD Million) by Type (2018-2023)

Table 90. Global Noninvasive Prenatal Gene Testing Technology Consumption Value Share by Type (2018-2023)

Table 91. Global Noninvasive Prenatal Gene Testing Technology Consumption Value Forecast by Type (2024-2029)

Table 92. Global Noninvasive Prenatal Gene Testing Technology Consumption Value by Application (2018-2023)

Table 93. Global Noninvasive Prenatal Gene Testing Technology Consumption Value Forecast by Application (2024-2029)

Table 94. North America Noninvasive Prenatal Gene Testing Technology Consumption Value by Type (2018-2023) & (USD Million)

Table 95. North America Noninvasive Prenatal Gene Testing Technology Consumption Value by Type (2024-2029) & (USD Million)

Table 96. North America Noninvasive Prenatal Gene Testing Technology Consumption Value by Application (2018-2023) & (USD Million)

Table 97. North America Noninvasive Prenatal Gene Testing Technology Consumption Value by Application (2024-2029) & (USD Million)

Table 98. North America Noninvasive Prenatal Gene Testing Technology Consumption Value by Country (2018-2023) & (USD Million)

Table 99. North America Noninvasive Prenatal Gene Testing Technology Consumption Value by Country (2024-2029) & (USD Million)

Table 100. Europe Noninvasive Prenatal Gene Testing Technology Consumption Value by Type (2018-2023) & (USD Million)

Table 101. Europe Noninvasive Prenatal Gene Testing Technology Consumption Value by Type (2024-2029) & (USD Million)

Table 102. Europe Noninvasive Prenatal Gene Testing Technology Consumption Value by Application (2018-2023) & (USD Million)

Table 103. Europe Noninvasive Prenatal Gene Testing Technology Consumption Value by Application (2024-2029) & (USD Million)

Table 104. Europe Noninvasive Prenatal Gene Testing Technology Consumption Value by Country (2018-2023) & (USD Million)

Table 105. Europe Noninvasive Prenatal Gene Testing Technology Consumption Value by Country (2024-2029) & (USD Million)

Table 106. Asia-Pacific Noninvasive Prenatal Gene Testing Technology Consumption Value by Type (2018-2023) & (USD Million)

Table 107. Asia-Pacific Noninvasive Prenatal Gene Testing Technology Consumption Value by Type (2024-2029) & (USD Million)

Table 108. Asia-Pacific Noninvasive Prenatal Gene Testing Technology Consumption Value by Application (2018-2023) & (USD Million)

Table 109. Asia-Pacific Noninvasive Prenatal Gene Testing Technology Consumption Value by Application (2024-2029) & (USD Million)

Table 110. Asia-Pacific Noninvasive Prenatal Gene Testing Technology Consumption Value by Region (2018-2023) & (USD Million)

Table 111. Asia-Pacific Noninvasive Prenatal Gene Testing Technology Consumption Value by Region (2024-2029) & (USD Million)

Table 112. South America Noninvasive Prenatal Gene Testing Technology Consumption Value by Type (2018-2023) & (USD Million)

Table 113. South America Noninvasive Prenatal Gene Testing Technology Consumption Value by Type (2024-2029) & (USD Million)

Table 114. South America Noninvasive Prenatal Gene Testing Technology Consumption Value by Application (2018-2023) & (USD Million)

Table 115. South America Noninvasive Prenatal Gene Testing Technology Consumption Value by Application (2024-2029) & (USD Million)

Table 116. South America Noninvasive Prenatal Gene Testing Technology Consumption Value by Country (2018-2023) & (USD Million)

Table 117. South America Noninvasive Prenatal Gene Testing Technology Consumption Value by Country (2024-2029) & (USD Million)

Table 118. Middle East & Africa Noninvasive Prenatal Gene Testing Technology Consumption Value by Type (2018-2023) & (USD Million)

Table 119. Middle East & Africa Noninvasive Prenatal Gene Testing Technology Consumption Value by Type (2024-2029) & (USD Million)

Table 120. Middle East & Africa Noninvasive Prenatal Gene Testing Technology Consumption Value by Application (2018-2023) & (USD Million)

Table 121. Middle East & Africa Noninvasive Prenatal Gene Testing Technology Consumption Value by Application (2024-2029) & (USD Million)

Table 122. Middle East & Africa Noninvasive Prenatal Gene Testing Technology Consumption Value by Country (2018-2023) & (USD Million)

Table 123. Middle East & Africa Noninvasive Prenatal Gene Testing Technology Consumption Value by Country (2024-2029) & (USD Million)

Table 124. Noninvasive Prenatal Gene Testing Technology Raw Material

Table 125. Key Suppliers of Noninvasive Prenatal Gene Testing Technology Raw Materials

List of Figures

Figure 1. Noninvasive Prenatal Gene Testing Technology Picture

Figure 2. Global Noninvasive Prenatal Gene Testing Technology Consumption Value by Type, (USD Million), 2018 & 2022 & 2029

Figure 3. Global Noninvasive Prenatal Gene Testing Technology Consumption Value Market Share by Type in 2022

Figure 4. NIPT

Figure 5. NIPT Plus

Figure 6. Global Noninvasive Prenatal Gene Testing Technology Consumption Value by Type, (USD Million), 2018 & 2022 & 2029

Figure 7. Noninvasive Prenatal Gene Testing Technology Consumption Value Market Share by Application in 2022

Figure 8. Chromosomal Abnormalities Picture

Figure 9. Assisted Reproduction Picture

Figure 10. Others Picture

Figure 11. Global Noninvasive Prenatal Gene Testing Technology Consumption Value, (USD Million): 2018 & 2022 & 2029

Figure 12. Global Noninvasive Prenatal Gene Testing Technology Consumption Value and Forecast (2018-2029) & (USD Million)

Figure 13. Global Market Noninvasive Prenatal Gene Testing Technology Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)

Figure 14. Global Noninvasive Prenatal Gene Testing Technology Consumption Value Market Share by Region (2018-2029)

Figure 15. Global Noninvasive Prenatal Gene Testing Technology Consumption Value Market Share by Region in 2022

Figure 16. North America Noninvasive Prenatal Gene Testing Technology Consumption Value (2018-2029) & (USD Million)

Figure 17. Europe Noninvasive Prenatal Gene Testing Technology Consumption Value (2018-2029) & (USD Million)

Figure 18. Asia-Pacific Noninvasive Prenatal Gene Testing Technology Consumption Value (2018-2029) & (USD Million)

Figure 19. South America Noninvasive Prenatal Gene Testing Technology Consumption Value (2018-2029) & (USD Million)

Figure 20. Middle East and Africa Noninvasive Prenatal Gene Testing Technology Consumption Value (2018-2029) & (USD Million)

Figure 21. Global Noninvasive Prenatal Gene Testing Technology Revenue Share by Players in 2022

Figure 22. Noninvasive Prenatal Gene Testing Technology Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022

Figure 23. Global Top 3 Players Noninvasive Prenatal Gene Testing Technology Market Share in 2022

Figure 24. Global Top 6 Players Noninvasive Prenatal Gene Testing Technology Market Share in 2022

Figure 25. Global Noninvasive Prenatal Gene Testing Technology Consumption Value Share by Type (2018-2023)

Figure 26. Global Noninvasive Prenatal Gene Testing Technology Market Share Forecast by Type (2024-2029)

Figure 27. Global Noninvasive Prenatal Gene Testing Technology Consumption Value Share by Application (2018-2023)

Figure 28. Global Noninvasive Prenatal Gene Testing Technology Market Share Forecast by Application (2024-2029)

Figure 29. North America Noninvasive Prenatal Gene Testing Technology Consumption Value Market Share by Type (2018-2029)

Figure 30. North America Noninvasive Prenatal Gene Testing Technology Consumption Value Market Share by Application (2018-2029)

Figure 31. North America Noninvasive Prenatal Gene Testing Technology Consumption Value Market Share by Country (2018-2029)

Figure 32. United States Noninvasive Prenatal Gene Testing Technology Consumption Value (2018-2029) & (USD Million)

Figure 33. Canada Noninvasive Prenatal Gene Testing Technology Consumption Value (2018-2029) & (USD Million)

Figure 34. Mexico Noninvasive Prenatal Gene Testing Technology Consumption Value (2018-2029) & (USD Million)

Figure 35. Europe Noninvasive Prenatal Gene Testing Technology Consumption Value Market Share by Type (2018-2029)

Figure 36. Europe Noninvasive Prenatal Gene Testing Technology Consumption Value Market Share by Application (2018-2029)

Figure 37. Europe Noninvasive Prenatal Gene Testing Technology Consumption Value Market Share by Country (2018-2029)

Figure 38. Germany Noninvasive Prenatal Gene Testing Technology Consumption Value (2018-2029) & (USD Million)

Figure 39. France Noninvasive Prenatal Gene Testing Technology Consumption Value (2018-2029) & (USD Million)

Figure 40. United Kingdom Noninvasive Prenatal Gene Testing Technology Consumption Value (2018-2029) & (USD Million)

Figure 41. Russia Noninvasive Prenatal Gene Testing Technology Consumption Value (2018-2029) & (USD Million)

Figure 42. Italy Noninvasive Prenatal Gene Testing Technology Consumption Value (2018-2029) & (USD Million)

Figure 43. Asia-Pacific Noninvasive Prenatal Gene Testing Technology Consumption Value Market Share by Type (2018-2029)

Figure 44. Asia-Pacific Noninvasive Prenatal Gene Testing Technology Consumption Value Market Share by Application (2018-2029)

Figure 45. Asia-Pacific Noninvasive Prenatal Gene Testing Technology Consumption Value Market Share by Region (2018-2029)

Figure 46. China Noninvasive Prenatal Gene Testing Technology Consumption Value (2018-2029) & (USD Million)

Figure 47. Japan Noninvasive Prenatal Gene Testing Technology Consumption Value (2018-2029) & (USD Million)

Figure 48. South Korea Noninvasive Prenatal Gene Testing Technology Consumption Value (2018-2029) & (USD Million)

Figure 49. India Noninvasive Prenatal Gene Testing Technology Consumption Value (2018-2029) & (USD Million)

Figure 50. Southeast Asia Noninvasive Prenatal Gene Testing Technology Consumption Value (2018-2029) & (USD Million)

Figure 51. Australia Noninvasive Prenatal Gene Testing Technology Consumption Value (2018-2029) & (USD Million)

Figure 52. South America Noninvasive Prenatal Gene Testing Technology Consumption Value Market Share by Type (2018-2029)

Figure 53. South America Noninvasive Prenatal Gene Testing Technology Consumption Value Market Share by Application (2018-2029)

Figure 54. South America Noninvasive Prenatal Gene Testing Technology Consumption Value Market Share by Country (2018-2029)

Figure 55. Brazil Noninvasive Prenatal Gene Testing Technology Consumption Value (2018-2029) & (USD Million)

Figure 56. Argentina Noninvasive Prenatal Gene Testing Technology Consumption Value (2018-2029) & (USD Million)

Figure 57. Middle East and Africa Noninvasive Prenatal Gene Testing Technology Consumption Value Market Share by Type (2018-2029)

Figure 58. Middle East and Africa Noninvasive Prenatal Gene Testing Technology Consumption Value Market Share by Application (2018-2029)

Figure 59. Middle East and Africa Noninvasive Prenatal Gene Testing Technology Consumption Value Market Share by Country (2018-2029)

Figure 60. Turkey Noninvasive Prenatal Gene Testing Technology Consumption Value (2018-2029) & (USD Million)

Figure 61. Saudi Arabia Noninvasive Prenatal Gene Testing Technology Consumption Value (2018-2029) & (USD Million)

Figure 62. UAE Noninvasive Prenatal Gene Testing Technology Consumption Value (2018-2029) & (USD Million)

Figure 63. Noninvasive Prenatal Gene Testing Technology Market Drivers

Figure 64. Noninvasive Prenatal Gene Testing Technology Market Restraints

Figure 65. Noninvasive Prenatal Gene Testing Technology Market Trends

Figure 66. Porters Five Forces Analysis

Figure 67. Manufacturing Cost Structure Analysis of Noninvasive Prenatal Gene Testing Technology in 2022

Figure 68. Manufacturing Process Analysis of Noninvasive Prenatal Gene Testing Technology

Figure 69. Noninvasive Prenatal Gene Testing Technology Industrial Chain

Figure 70. Methodology

Figure 71. Research Process and Data Source